Sub-optimal responders following controlled ovarian stimulation: An overlooked group?

Human Reproduction

Volumn 30, Issue 9, 2015, Pages 2005-2008

  Polyzos, N P ^a,b   Sunkara, S K ^c  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

controlled ovarian stimulation; individualized IVF; ovarian response; sub optimal responders; tailored ovarian stimulation

Indexed keywords

FOLLITROPIN RECEPTOR; LUTEINIZING HORMONE BETA SUBUNIT;

BIRTH RATE; CONTROLLED OVARIAN STIMULATION; FEMALE; FERTILIZATION IN VITRO; GENETIC VARIABILITY; HUMAN; LIVE BIRTH; META ANALYSIS (TOPIC); OOCYTE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY RATE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFERENCE VALUE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; CELL COUNT; EVIDENCE BASED MEDICINE; TREATMENT OUTCOME;

ADULT; CELL COUNT; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; OOCYTES; OVULATION INDUCTION; REFERENCE VALUES; TREATMENT OUTCOME;

EID: 84940743771     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dev149     Document Type: Review

References (27)

1. Alviggi C, Clarizia R, Pettersson K, Mollo A, Humaidan P, Strina I, Coppola M, Ranieri A, D'Uva M, De Placido G. Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism. Reprod Biomed Online 2011; 22 Suppl 1: S67-S72
2. Arce JC, Andersen AN, Fernandez-Sanchez M, Visnova H, Bosch E, Garcia-Velasco JA, Barri P, de Sutter P, Klein BM, Fauser BC. Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimullerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril 2014; 102: 1633-1640.e5
3. Baart EB, Martini E, Eijkemans MJ, Van Opstal D, Beckers NG, Verhoeff A, Macklon NS, Fauser BC. Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod 2007; 22: 980-988
4. Briggs R, Kovacs G, MacLachlan V, Motteram C, Baker HW. Can you ever collect too many oocytes? Hum Reprod 2015; 30: 81-87
5. Broer SL, Dolleman M, van Disseldorp J, Broeze KA, Opmeer BC, Bossuyt PM, Eijkemans MJ, Mol BW, Broekmans FJ, IPD-Export Study Group. Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-Analysis. Fertil Steril 2013; 100: 420-429.e7
6. Bu Z, Zhao F, Wang K, Guo Y, Su Y, Zhai J, Sun Y. Serum progesterone elevation adversely affects cumulative live birth rate in different ovarian responders during in vitro fertilization and embryo transfer: a large retrospective study. PLoS One 2014; 9: e100011
7. Devroey P, Boostanfar R, Koper NP, Mannaerts BM, Ijzerman-Boon PC, Fauser BC, Investigators E A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol. Hum Reprod 2009; 24: 3063-3072
8. Devroey P, Polyzos NP, Blockeel C. An OHSS-Free Clinic by segmentation of IVF treatment. Hum Reprod 2011; 26: 2593-2597
9. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L, ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 2011; 26: 1616-1624
10. Hamoda H, Sunkara S, Khalaf Y, Braude P, El-Toukhy T. Outcome of fresh IVF/ICSI cycles in relation to the number of oocytes collected: a review of 4, 701 treatment cycles. Hum Reprod 2010; 25: 147
11. Joo BS, Park SH, An BM, Kim KS, Moon SE, Moon HS. Serum estradiol levels during controlled ovarian hyperstimulation influence the pregnancy outcome of in vitro fertilization in a concentration-dependent manner. Fertil Steril 2010; 93: 442-446
12. Kailasam C, Keay SD, Wilson P, Ford WC, Jenkins JM. Defining poor ovarian response during IVF cycles, in women aged , 40 years, and its relationship with treatment outcome. Hum Reprod 2004; 19: 1544-1547
13. Konig TE, van der Houwen LE, Overbeek A, Hendriks ML, Beutler-Beemsterboer SN, Kuchenbecker WK, Renckens CN, Bernardus RE, Schats R, Homburg R et al. Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study. Hum Reprod 2013; 28: 2804-2812
14. Labarta E, Bosch E, Alama P, Rubio C, Rodrigo L, Pellicer A. Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in vitro fertilization cycles. J Clin Endocrinol Metab 2012; 97: E1987-E1994
15. Polyzos NP, Devroey P A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril 2011; 96: 1058-1061.e7
16. Polyzos NP, Blockeel C, Verpoest W, De Vos M, Stoop D, Vloeberghs V, Camus M, Devroey P, Tournaye H. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria. Hum Reprod 2012; 27: 3481-3486
17. Polyzos NP, Nwoye M, Corona R, Blockeel C, Stoop D, Haentjens P, Camus M, Tournaye H. Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI. Reprod Biomed Online 2014; 28: 469-474
18. Simoni M, Nieschlag E, Gromoll J. Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Hum Reprod Update 2002; 8: 413-421
19. Steward RG, Lan L, Shah AA, Yeh JS, Price TM, Goldfarb JM, Muasher SJ. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256, 381 in vitro fertilization cycles. Fertil Steril 2014; 101: 967-973
20. Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod 2011; 26: 1768-1774
21. Sunkara SK, Coomarasamy A, Faris R, Braude P, Khalaf Y. Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial. Fertil Steril 2014; 101: 147-153
22. Trounson AO, Leeton JF, Wood C, Webb J, Wood J. Pregnancies in humans by fertilization in vitro and embryo transfer in the controlled ovulatory cycle. Science 1981; 212: 681-682
23. van der Gaast MH, Eijkemans MJ, van der Net JB, de Boer EJ, Burger CW, van Leeuwen FE, Fauser BC, Macklon NS. Optimum number of oocytes for a successful first IVF treatment cycle. Reprod Biomed Online 2006; 13: 476-480
24. van Loendersloot LL, vanWely M, Limpens J, Bossuyt PM, Repping S, van der Veen F. Predictive factors in in vitro fertilization (IVF): a systematic review and meta-Analysis. Hum Reprod Update 2010; 16: 577-589
25. vanWely M, Kwan I, Burt AL, Thomas J, Vail A, Van der Veen F, Al-Inany HG. Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. Cochrane Database Syst Rev 2011; CD005354
26. Verberg MF, Eijkemans MJ, Macklon NS, Heijnen EM, Baart EB, Hohmann FP, Fauser BC, Broekmans FJ. The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-Analysis. Hum Reprod Update 2009; 15: 5-12
27. Xiao JS, Su CM, Zeng XT. Comparisons of GnRH antagonist versus GnRH agonist protocol in supposed normal ovarian responders undergoing IVF: a systematic review and meta-Analysis. PLoS One 2014; 9: e106854